Fujifilm Holdings America Corporation
Based in NY
🤖
AI Overview
With $2.1M in lobbying spend across 11 quarterly filings, Fujifilm Holdings America Corporation is a significant lobbying presence. Their lobbying covers 12 issue areas. Active from 2023 to 2025.
$2.1M
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
12
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $68K |
| 2024 | $915K |
| 2025 | $1.1M |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Manufacturing, Chemicals, Science/Technology, Budget/Appropriations and 7 more
- •Reauthorization of Pandemic and All- Hazards Preparedness and Advancing Innovation Act
- •Contract development and manufacturing, medical devices, life science issues, appropriations and budget, domestic manufacturing, electronic materials
Related Analysis
📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders
🏭 Tech Lobbying
Industry overview and top spenders
🏭 Defense Lobbying
Industry overview and top spenders
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.